Founded in 2015, Arcus Biosciences is a highly productive, clinical-stage, global biopharmaceutical company with the goal of developing best-in-class molecules and combination therapies for people with cancer. Our team of scientists, physicians, advisors and other leaders is focused on targeting well-understood biological targets and pathways where there is an opportunity to develop new medicines with a potentially improved safety and efficacy profile. ARCUS IS AT THE FOREFRONT OF DESIGNING COMBINATION THERAPIES, WITH BEST-IN-CLASS POTENTIAL, IN OUR RELENTLESS PURSUIT OF CURES FOR CANCER. One of Arcus’s key competitive advantages is a highly productive, industry-leading team of individuals that runs our world-class discovery engine and development organization. We believe that discovery is not a commodity, and we have invested in building exceptional small molecule, medicinal chemistry and antibody capabilities to optimize the combinability of molecules within our portfolio.